Johnson & Johnson Price to Book Ratio 2006-2018 | JNJ

Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of February 18, 2019 is 5.66.
Johnson & Johnson Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2019-02-15 136.38 5.66
2018-09-30 137.30 $24.09 5.70
2018-06-30 119.77 $23.45 5.11
2018-03-31 125.57 $23.58 5.32
2017-12-31 136.04 $22.43 6.07
2017-09-30 125.82 $27.55 4.57
2017-06-30 127.21 $26.78 4.75
2017-03-31 118.99 $26.10 4.56
2016-12-31 109.35 $26.02 4.20
2016-09-30 111.35 $26.73 4.17
2016-06-30 113.58 $26.47 4.29
2016-03-31 100.60 $26.40 3.81
2015-12-31 94.82 $25.82 3.67
2015-09-30 85.55 $25.86 3.31
2015-06-30 88.62 $25.69 3.45
2015-03-31 90.81 $24.45 3.71
2014-12-31 93.74 $25.06 3.74
2014-09-30 94.93 $27.31 3.48
2014-06-30 92.55 $27.65 3.35
2014-03-31 86.30 $27.08 3.19
2013-12-31 79.89 $26.25 3.04
2013-09-30 75.09 $24.75 3.03
2013-06-30 73.82 $24.75 2.98
2013-03-31 69.57 $23.85 2.92
2012-12-31 59.34 $23.33 2.54
2012-09-30 57.83 $23.08 2.51
2012-06-30 56.19 $21.97 2.56
2012-03-31 54.33 $22.35 2.43
2011-12-31 53.55 $20.95 2.56
2011-09-30 51.53 $22.52 2.29
2011-06-30 53.34 $22.67 2.35
2011-03-31 47.10 $21.86 2.15
2010-12-31 48.73 $20.66 2.36
2010-09-30 48.40 $20.85 2.32
2010-06-30 45.70 $19.19 2.38
2010-03-31 50.00 $19.19 2.61
2009-12-31 49.01 $18.37 2.67
2009-09-30 45.97 $18.27 2.52
2009-06-30 42.54 $16.79 2.53
2009-03-31 39.05 $15.87 2.46
2008-12-31 44.05 $15.35 2.87
2008-09-30 50.60 $16.45 3.08
2008-06-30 46.70 $16.61 2.81
2008-03-31 46.75 $16.19 2.89
2007-12-31 47.76 $15.25 3.13
2007-09-30 46.75 $15.17 3.08
2007-06-30 43.56 $14.90 2.92
2007-03-31 42.32 $14.14 2.99
2006-12-31 46.09 $13.59 3.39
2006-09-30 45.08 $13.97 3.23
2006-06-30 41.36 $13.89 2.98
2006-03-31 40.62 $13.83 2.94
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $365.894B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $252.401B 14.13
Merck (MRK) United States $215.183B 18.39
Novartis AG (NVS) Switzerland $207.623B 17.66
Eli Lilly (LLY) United States $129.746B 22.03
Novo Nordisk (NVO) Denmark $123.032B 19.90
AbbVie (ABBV) United States $121.616B 10.22
Sanofi (SNY) France $106.719B 13.17
AstraZeneca (AZN) United Kingdom $103.646B 11.83
GlaxoSmithKline (GSK) United Kingdom $102.300B 13.43
Bristol-Myers Squibb (BMY) United States $84.336B 12.98